secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOXYTRAN, INC (BIXT)
CIK:        0001445815
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001539497-22-001158
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioxytran announces PCT publication of two COVID-19 treatment patents and USPTO trademark approval for ProLectin
--------------------------------------------------------------------------------

- PCT published patent WO 2022/099052 for polysaccharides treating SARS-CoV-2, filed Nov 2021.
- PCT published patent WO 2022/099061 for IV-administered pectin polysaccharides treating SARS-CoV-2.
- USPTO approved trademark 'ProLectin' for publication in Trademark Official Gazette on June 28, 2022.
- Both patents claim priority date of November 6, 2020.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445815/000153949722001158/0001539497-22-001158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445815/000153949722001158/n2583_x45-8k.htm
  HTML page:      https://secwatch.observer/filing/0001539497-22-001158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer